Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
1.
Medicine (Baltimore) ; 101(41): e30400, 2022 Oct 14.
Artigo em Inglês | MEDLINE | ID: mdl-36254051

RESUMO

Spain's rate of new human immunodeficiency virus (HIV) diagnoses exceeds that of the European Economic Area average (8.6 vs 5.6:100,000 in 2018). The country has failed to meet the first of United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 targets for HIV control by 2020, with 87.0% of people living with HIV knowing their status, and late presentation rates of 47.6% and 51.5% country-wide and in the Valencian autonomous community, respectively. Advancing screening and linkage to care (SLTC) practices is necessary to effectively control the epidemic. The Valencia Viral Screening (CRIVALVIR) project adopted the TEST model for opportunistic and systematic HIV SLTC in individuals aged 18 to 80 who required blood work for any purpose, as of February 2019. SLTC was integrated into routine clinical workflow across primary care centers serving a population of 360,000 people in Valencia, Spain. Our project successfully upscaled total HIV testing by 194% to over 32,000 patients tested in 14 months. We found an overall prevalence of 0.13% (0.08-0.21) among those screened per protocol (n = 13,061), with foreign-born citizens presenting a 12.5 times significantly higher likelihood of acquiring HIV (95% confidence interval 4.63-33.96, P < .0001). We improved late presentation by 18.2 percentage points and prevented an estimated 58 to 70 new secondary infections. HIV screening of the general population in primary care is an effective strategy for achieving timely diagnosis and preventing new infections. Opportunistic, systematic, opt-out approaches are essential to control the HIV epidemic.


Assuntos
Infecções por HIV , Melhoria de Qualidade , Atenção à Saúde , Infecções por HIV/diagnóstico , Infecções por HIV/epidemiologia , Infecções por HIV/prevenção & controle , Teste de HIV , Humanos , Programas de Rastreamento , Espanha/epidemiologia
2.
Ann Hepatol ; 27(1): 100542, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-34571265

RESUMO

INTRODUCTION AND OBJECTIVES: Implementation of a one-step strategy for diagnosis of active Hepatitis C virus (HCV) infection would encourage the early diagnosis and reduce the time to access antiviral treatments. The aim of this study was to evaluate the impact of a HCV one-step diagnosis compared to the traditional two-step protocol in terms of the time required for patients to be seen by specialists and the time taken to start antiviral treatment. MATERIAL AND METHODS: A comparative study was carried out to assess two diagnostic algorithms (one-step and two-step) for active HCV infection. Serological markers were quantified using the same serum sample to determine both anti-HCV antibodies (HCV-Ab) and HCV core antigen (HCV-cAg) by Architect i2000 SR kit. In this period, a multidisciplinary procedure was started for telematics referral of viremic patients. RESULTS: One-step approach reduced the time required for patient HCV diagnosis, referral to a specialist, access to treatment, and eliminated the loss of patients to follow-up. Significant differences were observed between one-step and two-step diagnosis methods in the time required for patients to be seen by a specialist (18 days [Interquartile range (IQR) = 14-42] versus 107 days [IQR = 62-148]) and for the initiation of treatment (54 days [IQR = 43-75] versus 200 days [IQR = 116-388]), mainly for patients with advanced fibrosis (35 days [IQR = 116-388] versus 126 days [IQR = 152-366]). CONCLUSIONS: Use of HCV-cAg has proven to be a useful tool for screening patients with active hepatitis C. The development of a multidisciplinary protocol for the communication of results improved the efficiency of the care process.


Assuntos
Antivirais/uso terapêutico , Hepacivirus/imunologia , Anticorpos Anti-Hepatite C/análise , Antígenos da Hepatite C/análise , Hepatite C/diagnóstico , Telemedicina/métodos , Feminino , Hepatite C/tratamento farmacológico , Hepatite C/virologia , Humanos , Masculino
3.
PLoS Comput Biol ; 17(6): e1009166, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-34181647

RESUMO

As genomic architectures become more complex, they begin to accumulate degenerate and redundant elements. However, analyses of the molecular mechanisms underlying these genetic architecture features remain scarce, especially in compact but sufficiently complex genomes. In the present study, we followed a proteomic approach together with a computational network analysis to reveal molecular signatures of protein function degeneracy from a plant virus (as virus-host protein-protein interactions). We employed affinity purification coupled to mass spectrometry to detect several host factors interacting with two proteins of Citrus tristeza virus (p20 and p25) that are known to function as RNA silencing suppressors, using an experimental system of transient expression in a model plant. The study was expanded by considering two different isolates of the virus, and some key interactions were confirmed by bimolecular fluorescence complementation assays. We found that p20 and p25 target a common set of plant proteins including chloroplastic proteins and translation factors. Moreover, we noted that even specific targets of each viral protein overlap in function. Notably, we identified argonaute proteins (key players in RNA silencing) as reliable targets of p20. Furthermore, we found that these viral proteins preferentially do not target hubs in the host protein interactome, but elements that can transfer information by bridging different parts of the interactome. Overall, our results demonstrate that two distinct proteins encoded in the same viral genome that overlap in function also overlap in their interactions with the cell proteome, thereby highlighting an overlooked connection from a degenerate viral system.


Assuntos
Closterovirus/genética , Interferência de RNA , RNA Viral/genética , Proteínas Argonautas/metabolismo , Citrus/metabolismo , Citrus/virologia , Closterovirus/metabolismo , Biologia Computacional , Genoma Viral , Interações entre Hospedeiro e Microrganismos/genética , Interações entre Hospedeiro e Microrganismos/fisiologia , Modelos Biológicos , Doenças das Plantas/virologia , Proteínas de Plantas/metabolismo , Mapas de Interação de Proteínas , Proteômica , Proteínas Repressoras/genética , Proteínas Repressoras/metabolismo , /virologia , Proteínas Virais/genética , Proteínas Virais/metabolismo
6.
Helicobacter ; 24(3): e12584, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30990575

RESUMO

BACKGROUND: Susceptibility-guided treatment has been proposed as a way to improve Helicobacter pylori eradication rates. Evidence on its efficacy for rescue therapy is very scarce. The aim of this study was to indirectly assess the applicability and effectiveness of susceptibility-guided treatment by evaluating (a) the rate of acceptance of endoscopy, (b) its success in detecting resistances, and (c) infection cure rates in patients harboring strains found to be susceptible to the antibiotics administered in clinical trials in which the efficacy of second-line treatments was reported. METHODS: A systematic review of studies evaluating second-line H pylori treatment was carried out in multiple databases. Studies reporting antibiotic susceptibility evaluation and/or cure rates in patients harboring sensitive and resistant strains were selected. Data were extracted in duplicate. RESULTS: The systematic review identified 36 eligible studies. Acceptance was evaluated in only one study of 60 patients, of whom only 38 agreed to endoscopy. Among the 2890 patients who received endoscopy and culture, resistances were finally determined in 86.5%. Cure rate was 72.5% in the 113 patients harboring a clarithromycin-susceptible strain after previous clarithromycin treatment, 93.5% in the 765 patients harboring a metronidazole-susceptible strain, and 83.8% in the 192 patients harboring a levofloxacin-susceptible strain. No studies with repeated administration of levofloxacin or metronidazole were found. CONCLUSION: Even if the culture shows a clarithromycin-sensitive strain, repeating clarithromycin after a first failure should be discouraged. Susceptibility-guided treatment alone did not achieve adequate cure rates for rescue therapies. Additional measures are needed to design rescue treatments that consistently achieve excellent cure rates.


Assuntos
Antibacterianos/uso terapêutico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/efeitos dos fármacos , Amoxicilina/uso terapêutico , Claritromicina/uso terapêutico , Endoscopia , Infecções por Helicobacter/microbiologia , Humanos , Levofloxacino/uso terapêutico , Metronidazol/uso terapêutico , Resultado do Tratamento
9.
Gastroenterol. hepatol. (Ed. impr.) ; 41(10): 654-662, dic. 2018. tab, graf
Artigo em Espanhol | IBECS | ID: ibc-178244

RESUMO

No hay datos sistemáticos sobre cuáles son las tasas de resistencia a antibióticos tras el fracaso de un primer tratamiento erradicador. El objetivo del estudio es determinar la prevalencia de las resistencias secundarias a los antibióticos mediante una revisión sistemática de estudios que evaluaban las resistencias secundarias de Helicobacter pylori. Se identificaron 31 estudios (2.787 pacientes). Se determinaron resistencias en 1.764 pacientes. El 99,1% de los pacientes recibieron claritromicina como tratamiento de primera línea, y un 58,7% desarrollaron resistencias. El 24,3% de los pacientes recibieron metronidazol, desarrollando resistencias el 89,7%. La resistencia secundaria a amoxicilina fue excepcional. Las resistencias secundarias tras un primer tratamiento son muy elevadas. Estos hallazgos dan soporte a la recomendación de no repetir claritromicina o metronidazol tras el fracaso de un primer tratamiento erradicador


There are no systematic data on the rates of antibiotic resistance after the failure of a first eradication treatment. The objective of this study was to determine the prevalence of secondary resistance to antibiotics by conducting a systematic review of studies evaluating the secondary resistance of Helicobacter pylori. We identified 31 studies (2,787 patients). Resistance was determined in 1,764 patients. A percentage of 99.1 of patients received clarithromycin as first-line treatment and 58.7% developed resistance. A percentage of 24.3 received metronidazole and 89.7% developed resistance. Secondary resistance to amoxicillin was extremely rare. Secondary resistance after first-line treatment was very common. These findings support the recommendation not to repeat clarithromycin or metronidazole after the failure of a first eradication treatment


Assuntos
Humanos , Helicobacter pylori , Farmacorresistência Bacteriana , Estudos Transversais/métodos , Prevalência , Claritromicina/uso terapêutico , Metronidazol/uso terapêutico , Amoxicilina/uso terapêutico , Ensaios Clínicos Controlados Aleatórios como Assunto , Estudo Observacional
12.
Gastroenterol Hepatol ; 41(10): 654-662, 2018 Dec.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-30180998

RESUMO

There are no systematic data on the rates of antibiotic resistance after the failure of a first eradication treatment. The objective of this study was to determine the prevalence of secondary resistance to antibiotics by conducting a systematic review of studies evaluating the secondary resistance of Helicobacter pylori. We identified 31 studies (2,787 patients). Resistance was determined in 1,764 patients. A percentage of 99.1 of patients received clarithromycin as first-line treatment and 58.7% developed resistance. A percentage of 24.3 received metronidazole and 89.7% developed resistance. Secondary resistance to amoxicillin was extremely rare. Secondary resistance after first-line treatment was very common. These findings support the recommendation not to repeat clarithromycin or metronidazole after the failure of a first eradication treatment.


Assuntos
Antibacterianos/uso terapêutico , Farmacorresistência Bacteriana Múltipla , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/efeitos dos fármacos , Antibacterianos/farmacologia , Claritromicina/farmacologia , Claritromicina/uso terapêutico , Substituição de Medicamentos , Infecções por Helicobacter/microbiologia , Humanos , Metronidazol/farmacologia , Metronidazol/uso terapêutico , Estudos Observacionais como Assunto , Ensaios Clínicos Controlados Aleatórios como Assunto , Estudos Retrospectivos , Falha de Tratamento
13.
Helicobacter ; 23(3): e12488, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29663581

RESUMO

BACKGROUND: Multiple Helicobacter pylori second-line schedules have been described as potentially useful. It remains unclear, however, which are the best combinations, and which features of second-line treatments are related to better cure rates. The aim of this study was to determine that second-line treatments achieved excellent (>90%) cure rates by performing a systematic review and when possible a meta-analysis. A meta-regression was planned to determine the characteristics of treatments achieving excellent cure rates. METHODS: A systematic review for studies evaluating second-line Helicobacter pylori treatment was carried out in multiple databases. A formal meta-analysis was performed when an adequate number of comparative studies was found, using RevMan5.3. A meta-regression for evaluating factors predicting cure rates >90% was performed using Stata Statistical Software. RESULTS: The systematic review identified 115 eligible studies, including 203 evaluable treatment arms. The results were extremely heterogeneous, with 61 treatment arms (30%) achieving optimal (>90%) cure rates. The meta-analysis favored quadruple therapies over triple (83.2% vs 76.1%, OR: 0.59:0.38-0.93; P = .02) and 14-day quadruple treatments over 7-day treatments (91.2% vs 81.5%, OR; 95% CI: 0.42:0.24-0.73; P = .002), although the differences were significant only in the per-protocol analysis. The meta-regression did not find any particular characteristics of the studies to be associated with excellent cure rates. CONCLUSION: Second-line Helicobacter pylori treatments achieving>90% cure rates are extremely heterogeneous. Quadruple therapy and 14-day treatments seem better than triple therapies and 7-day ones. No single characteristic of the treatments was related to excellent cure rates. Future approaches suitable for infectious diseases-thus considering antibiotic resistances-are needed to design rescue treatments that consistently achieve excellent cure rates.


Assuntos
Antibacterianos/uso terapêutico , Antiulcerosos/uso terapêutico , Infecções por Helicobacter/tratamento farmacológico , Inibidores da Bomba de Prótons/uso terapêutico , Antibacterianos/farmacologia , Antiulcerosos/farmacologia , Quimioterapia Combinada , Helicobacter pylori/efeitos dos fármacos , Humanos , Inibidores da Bomba de Prótons/farmacologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Terapia de Salvação/estatística & dados numéricos , Resultado do Tratamento
16.
Mol Plant Pathol ; 18(9): 1253-1266, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-27588892

RESUMO

Citrus tristeza virus (CTV) induces in the field the decline and death of citrus varieties grafted on sour orange (SO) rootstock, which has forced the use of alternative decline-tolerant rootstocks in affected countries, despite the highly desirable agronomic features of the SO rootstock. Declining citrus plants display phloem necrosis below the bud union. In addition, SO is minimally susceptible to CTV compared with other citrus varieties, suggesting partial resistance of SO to CTV. Here, by silencing different citrus genes with a Citrus leaf blotch virus-based vector, we have examined the implication of the RNA silencing and salicylic acid (SA) defence pathways in the resistance of SO to CTV. Silencing of the genes RDR1, NPR1 and DCL2/DCL4, associated with these defence pathways, enhanced virus spread and accumulation in SO plants in comparison with non-silenced controls, whereas silencing of the genes NPR3/NPR4, associated with the hypersensitive response, produced a slight decrease in CTV accumulation and reduced stunting of SO grafted on CTV-infected rough lemon plants. We also found that the CTV RNA silencing suppressors p20 and p23 also suppress the SA signalling defence, with the suppressor activity being higher in the most virulent isolates.


Assuntos
Closterovirus/genética , Doenças das Plantas/microbiologia , Plantas Geneticamente Modificadas/microbiologia , Ácido Salicílico/farmacologia , Vetores Genéticos/genética , Doenças das Plantas/genética , Plantas Geneticamente Modificadas/genética , Interferência de RNA
17.
J Antimicrob Chemother ; 71(10): 2740-53, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27342548

RESUMO

BACKGROUND: Due to clarithromycin resistance, the current efficacy of Helicobacter pylori first-line triple therapies including clarithromycin is low. It seems reasonable to explore alternative clarithromycin-free therapies. OBJECTIVES: The objective of this study was to evaluate the efficacy of triple therapy including a proton-pump inhibitor (PPI), amoxicillin and metronidazole (PAM) as first-line H. pylori therapy by systematic review and meta-analysis. METHODS: Studies evaluating PAM in adult patients were included. Meta-analyses comparing PAM with other treatments were performed. The primary endpoint was the ITT eradication rate for H. pylori first-line treatment. In addition, sensitivity analyses ascertained the effects of treatment schedule, dosage and duration on cure rates. RESULTS: Ninety-four studies (8061 patients) were included. Meta-analyses comparing PAM versus clarithromycin-including triple therapies showed a significant difference in favour of PPI, amoxicillin and clarithromycin (PAC) (70% versus 77.1%; OR = 0.70, 95% CI = 0.56-0.88) and PPI, metronidazole and clarithromycin (PMC) therapy (66.4% versus 77.7%; OR = 0.55, 95% CI = 0.39-0.76). Sensitivity analyses showed a similar efficacy of PAM versus PAC when drugs were administered for 14 days (80% versus 84%; OR = 0.70, 95% CI = 0.44-1.12). There were not enough studies to perform further comparisons. Number of antibiotic doses (P = 0.012), length of treatment (P < 0.001) and use of high metronidazole doses (P = 0.021) were related to higher cure rates in the sensitivity analysis including observational studies. CONCLUSIONS: PAM was less efficacious than clarithromycin-including triple therapies. However, its efficacy was similar to that of PAC when drugs were administered for 14 days, although ITT cure rates did not reach 90%. Use of 14 day, thrice daily and high-metronidazole-dose PAM treatments markedly increased the cure rate.


Assuntos
Amoxicilina/uso terapêutico , Antibacterianos/uso terapêutico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/efeitos dos fármacos , Metronidazol/uso terapêutico , Inibidores da Bomba de Prótons/uso terapêutico , Adulto , Amoxicilina/efeitos adversos , Antibacterianos/efeitos adversos , Antiulcerosos/uso terapêutico , Quimioterapia Combinada , Infecções por Helicobacter/microbiologia , Humanos , Metronidazol/efeitos adversos , Inibidores da Bomba de Prótons/efeitos adversos
18.
J Antimicrob Chemother ; 70(9): 2447-55, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26078393

RESUMO

BACKGROUND: The cure rate of standard triple therapy for Helicobacter pylori infection is unacceptably low. Susceptibility-guided therapies (SGTs) have been proposed as an alternative to standard empirical treatments. The aim of this study was to perform a systematic review and meta-analysis evaluating the efficacy of SGTs. METHODS: A systematic search was performed in multiple databases. Randomized controlled trials comparing cure rates of SGTs versus those of empirical therapy were selected and analysed separately for first- and second-line treatments. A meta-analysis was performed using risk ratio (RR) and number needed to treat (NNT) to measure the effect. RESULTS: Twelve studies were included in the meta-analysis. In first-line treatment, SGT was more efficacious than empirical 7-10 day triple therapy (RR 1.16, 95% CI 1.10-1.23, I (2) = 33%; NNT = 8). Most studies used a 7-10 day triple therapy and randomized the patients after endoscopy and/or culture, thus precluding the comparison of SGT versus non-invasive testing and empirical treatment in clinical practice. For second-line therapy, only four studies were found. Results were highly heterogeneous and no significant differences were found (RR 1.11, 95% CI 0.82-1.51, I (2) = 87%). CONCLUSIONS: Once endoscopy and culture have been performed, SGT is superior to empirical 7 or 10 day triple therapy for first-line treatment. Further studies are needed to evaluate the effectiveness of SGT in clinical practice, especially when compared with currently recommended first-line quadruple therapies.


Assuntos
Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Tratamento Farmacológico/métodos , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/efeitos dos fármacos , Infecções por Helicobacter/microbiologia , Helicobacter pylori/isolamento & purificação , Humanos , Testes de Sensibilidade Microbiana , Resultado do Tratamento
19.
Enferm Clin ; 18(1): 18-25, 2008.
Artigo em Espanhol | MEDLINE | ID: mdl-18218263

RESUMO

OBJECTIVE: To identify how nurses use the Internet through a survey performed in May 2005. METHOD: A descriptive cross-sectional study was performed. The information source was a survey sent electronically and through surface mail. The study population consisted of nursing professionals from distinct autonomous regions. RESULTS: The overall response rate was 40% (444 of 1,100). A total of 38.6% (184) of the nursing professionals used the Internet continually, especially men and nursing staff with a high level of English. The 5 most frequent reasons for surfing the net were searching for nursing literature (63% [264]), consulting the web pages of nursing journals (58.6% [256]), seeking information on drugs (55% [230]), seeking protocol manuals (50% [204]), and consulting the web pages of colleges of nursing (48). CONCLUSIONS: The behavior of nursing professionals is similar to that found among the general population in the "BBVA Foundation study of the Internet in Spain". Most nursing professionals are women. Male nursing professionals more frequently search for subjects related to nursing theory. Nurses use the Internet to search for nursing literature and consult journals, protocol manuals, and colleges of nursing, as well as to be familiar with the information aimed at patients.


Assuntos
Acesso à Informação , Disseminação de Informação , Internet/estatística & dados numéricos , Enfermeiras e Enfermeiros/estatística & dados numéricos , Humanos , Espanha/epidemiologia , Inquéritos e Questionários
20.
Enferm. clín. (Ed. impr.) ; 18(1): 18-25, ene. 2008. ilus, tab
Artigo em Es | IBECS | ID: ibc-058447

RESUMO

Objetivo. Conocer el uso que los profesionales de enfermería hacen de internet, empleando un procedimiento por encuesta durante el mes de mayo de 2005. Método. Estudio descriptivo transversal que utiliza encuesta por correo postal y electrónico como fuente de información. La población de estudio ha sido profesionales de enfermería de diferentes comunidades autónomas. Resultados. La tasa global de respuesta ha sido del 40% (444 de 1.100). Utiliza internet de forma continua el 38,6% (184), y hay diferencias a favor de los varones y de los profesionales que dominan el inglés. Los 5 motivos más frecuentes son: búsqueda de literatura de enfermería 63% (264); consultar páginas de revistas de enfermería 58,6% (256); información acerca de fármacos 55% (230); manuales de protocolos 50% (204), y consultar páginas de colegios profesionales 48. Conclusiones. Los profesionales de enfermería tienen un comportamiento similar al encontrado en población general en "el estudio de la Fundación BBVA sobre Internet en España". La enfermería es una profesión mayoritariamente desempeñada por mujeres. Los temas que constituyen el desarrollo teórico de nuestra disciplina se consultan con mayor frecuencia por los varones. Se accede a internet para buscar literatura de enfermería, consultar revistas, manuales de protocolos, consultar colegios profesionales y para conocer la información que circula en la red dirigida a los pacientes


Objective. To identify how nurses use the Internet through a survey performed in May 2005. Method. A descriptive cross-sectional study was performed. The information source was a survey sent electronically and through surface mail. The study population consisted of nursing professionals from distinct autonomous regions. Results. The overall response rate was 40% (444 of 1,100). A total of 38.6% (184) of the nursing professionals used the Internet continually, especially men and nursing staff with a high level of English. The 5 most frequent reasons for surfing the net were searching for nursing literature (63% [264]), consulting the web pages of nursing journals (58.6% [256]), seeking information on drugs (55% [230]), seeking protocol manuals (50% [204]), and consulting the web pages of colleges of nursing (48). Conclusions. The behavior of nursing professionals is similar to that found among the general population in the "BBVA Foundation study of the Internet in Spain". Most nursing professionals are women. Male nursing professionals more frequently search for subjects related to nursing theory. Nurses use the Internet to search for nursing literature and consult journals, protocol manuals, and colleges of nursing, as well as to be familiar with the information aimed at patients


Assuntos
Humanos , Enfermeiras e Enfermeiros/estatística & dados numéricos , Internet , Acesso à Informação , Coleta de Dados/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...